AstraZeneca's Tezspire gets FDA approval for nasal polyp condition
Go back to AstraZeneca's Tezspire gets FDA approval for nasal polyp condition| Amgen Inc (NASDAQ: AMGN) | Delayed: 369.53 +1.93 (0.53%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $367.60 | 52 Week High | $176.85 | |||
| Open | $364.20 | 52 Week Low | $133.64 | |||
| Day High | $369.76 | P/E | 55.65 | |||
| Day Low | $361.71 | EPS | $6.64 | |||
| Volume | 2,443,032 | |||||
| ASTRAZENECA PLC (NASDAQ: AZN) | Delayed: 92.77 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $92.77 | 52 Week High | $35.04 | |||
| Open | $92.77 | 52 Week Low | $26.97 | |||
| Day High | $92.77 | P/E | N/A | |||
| Day Low | $92.77 | EPS | $0.00 | |||
| Volume | 1,473,887 | |||||
